Invention Grant
- Patent Title: Dihydroisoquinoline compound
-
Application No.: US16477533Application Date: 2018-01-10
-
Publication No.: US10647712B2Publication Date: 2020-05-12
- Inventor: Cheng Peng , Qing Xu , Teng Feng , Xiashi Lv , Xiaogang Lai , Rui Cui , Shaoyun Zhang , Jian Han , Chaojun Gong , Zhaoxiong Cai , Yang Zhou , Gang Zou , Danbin Li , Haiqing Yuan , Zhen Jim Wu
- Applicant: SUZHOU ARK BIOPHARMACEUTICAL CO., LTD.
- Applicant Address: CN Suzhou
- Assignee: SUZHOU ARK BIOPHARMACEUTICAL CO., LTD.
- Current Assignee: SUZHOU ARK BIOPHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Suzhou
- Agency: SZDC Law PC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@3d19f39d
- International Application: PCT/CN2018/072057 WO 20180110
- International Announcement: WO2018/130152 WO 20180719
- Main IPC: C07D455/06
- IPC: C07D455/06
Abstract:
A compound of general formula I: is disclosed. The compound be used to prevent or treat hepatitis B virus infection.
Public/Granted literature
- US20190389855A1 DIHYDROISOQUINOLINE COMPOUND Public/Granted day:2019-12-26
Information query
